TrialEuropean journal of neurology2025

Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial.

Cristina Tassorelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.